Back
ACUTE PHOSPHATE NEPHROPATHY REPRESENTS A RARE PATHOLOGY CONTRIBUTING TO RENAL DISEASE. ITS ONSET MAY OCCUR WITHIN DAYS FOLLOWING EXPOSURE TO PHOSPHATE OR MANIFEST AFTER AN EXTENDED PERIOD OF SEVERAL MONTHS. IDENTIFIED RISK FACTORS INCLUDE ADVANCED AGE, FEMALE GENDER, PRE-EXISTING RENAL CONDITIONS, VOLUME DEPLETION, ULCERS IN THE DIGESTIVE MUCOSA, INTESTINAL OBSTRUCTION OR ILEUS, AND THE UTILIZATION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS). THE PROGRESSION OF THIS CONDITION EXHIBITS UNPREDICTABILITY, RANGING FROM ACUTE RENAL INJURY TO THE DEVELOPMENT OF CHRONIC RENAL DISEASE, ULTIMATELY NECESSITATING RENAL REPLACEMENT THERAPY.
THE CASE INVOLVED A DETAILED PRESENTATION OF A 67-YEAR-OLD WOMAN WITH NO PRIOR HISTORY OF RENAL DISEASE. SHE WAS ADMITTED DUE TO AN UNEXPLAINED DECLINE IN GLOMERULAR FILTRATION RATE, ACCOMPANIED BY SYMPTOMS OF ASTHENIA AND FUNCTIONAL CLASS III DYSPNEA OVER A 10-DAY PERIOD. THE PATIENT DENIED THE USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS.
INITIAL LABORATORY ASSESSMENTS REVEALED AN ELEVATED CREATININE LEVEL OF 2.3 MG/DL, CONTRASTING WITH PREVIOUSLY NORMAL VALUES. NON-TRANSFUSIONAL ANEMIA WAS ALSO OBSERVED. URINALYSIS SHOWED NO HEMATURIA OR PROTEINURIA, AND RENAL ULTRASOUND DISPLAYED NORMAL RESULTS.
A COMPREHENSIVE EVALUATION WAS UNDERTAKEN TO RULE OUT CARDIAC ETIOLOGIES, INCLUDING AN ECHOCARDIOGRAM INDICATING PRESERVED EJECTION FRACTION. ADDITIONALLY, AN IMMUNOLOGICAL PROFILE YIELDED NEGATIVE RESULTS.
IN THE ABSENCE OF A CLEAR ETIOLOGY FOR THE PERSISTENT RENAL FAILURE, A RENAL BIOPSY WAS PERFORMED. HISTOPATHOLOGICAL FINDINGS CONFIRMED THE PRESENCE OF CALCIUM DEPOSITS WITHIN THE RENAL TUBULES, CONSISTENT WITH ACUTE PHOSPHATE NEPHROPATHY. IMMUNOFLUORESCENCE STUDIES WERE NEGATIVE.
SUBSEQUENT INVESTIGATION REVEALED THE PRIOR USE OF ORAL SODIUM PHOSPHATE (OSP) AS COLONIC PREPARATION FOR A VIDEOCOLONOSCOPY ONE MONTH BEFORE THE ONSET OF SYMPTOMS, DURING WHICH THE PATIENT'S CREATININE WAS 0.69 MG/DL. DESPITE INTERVENTION, THE PATIENT CONTINUED TO EXPERIENCE A DECLINE IN GLOMERULAR FILTRATION RATE, NECESSITATING INITIATION OF PERITONEAL DIALYSIS WITH A CLEARANCE OF 15 ML/MIN.
THE PRESENTED CASE UNDERSCORES THE CLINICAL SIGNIFICANCE OF ACUTE PHOSPHATE NEPHROPATHY, A RARE ENTITY CONTRIBUTING TO RENAL IMPAIRMENT. THE PATIENT, A 67-YEAR-OLD WOMAN WITH NO PRIOR RENAL ISSUES, EXHIBITED A NOTABLE DECLINE IN RENAL FUNCTION ASSOCIATED WITH THE USE OF ORAL SODIUM PHOSPHATE FOR COLONIC PREPARATION. THE EVOLUTION OF THE CONDITION, FROM ACUTE RENAL INJURY TO CHRONIC KIDNEY DISEASE NECESSITATING PERITONEAL DIALYSIS, HIGHLIGHTS THE UNPREDICTABLE NATURE OF THIS PATHOLOGY.
THE DIAGNOSTIC JOURNEY INVOLVED A THOROUGH EXCLUSION OF ALTERNATIVE ETIOLOGIES, INCLUDING CARDIAC AND IMMUNOLOGICAL FACTORS. THE PIVOTAL ROLE OF RENAL BIOPSY IN CONFIRMING THE PRESENCE OF CALCIUM DEPOSITS WITHIN RENAL TUBULES SUBSTANTIATED THE DIAGNOSIS OF ACUTE PHOSPHATE NEPHROPATHY.
THIS CASE SERVES AS A REMINDER OF THE IMPORTANCE OF RECOGNIZING SUSCEPTIBLE INDIVIDUALS AND AVOIDING THE USE OF PHOSPHATE-CONTAINING LAXATIVES FOR PREVENTATIVE PURPOSES. EARLY IDENTIFICATION AND INTERVENTION ARE CRUCIAL IN MITIGATING THE RISK OF PROGRESSION TO END-STAGE RENAL DISEASE. CLINICIANS SHOULD MAINTAIN A HIGH INDEX OF SUSPICION WHEN FACED WITH UNEXPLAINED RENAL DYSFUNCTION, PARTICULARLY IN THE CONTEXT OF RECENT PHOSPHATE EXPOSURE.